High expression of VIRMA has been verified to predict poor survival in multiple cancers, such as breast cancer [20, 41, 42], liver cancer [29, 43], kidney cancer [44] and prostate cancer [58]. This evidence concerns the gene VIRMA and breast carcinoma.